Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
BOLT on Nasdaq
Shares outstanding
1,910,829
Price per share
$5.93
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
804,036
Total reported value
$4,277,487
% of total 13F portfolios
0%
Share change
-83,489
Value change
-$449,315
Number of holders
24
Price from insider filings
$5.93
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TANG CAPITAL MANAGEMENT LLC 3.5% -58% $355,790 -$531,990 66,879 -60% TANG CAPITAL MANAGEMENT, LLC 30 Sep 2025

As of 30 Sep 2025, 24 institutional investors reported holding 804,036 shares of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT). This represents 42% of the company’s total 1,910,829 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) together control 42% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Vivo Capital, LLC 9.2% 176,064 0% 0.08% $936,660
Sofinnova Investments, Inc. 7.2% 137,721 0% 0.04% $732,676
Pivotal bioVenture Partners Investment Advisor LLC 4.9% 94,573 0% 0.29% $503,128
TANG CAPITAL MANAGEMENT LLC 3.5% 66,879 -60% 0.01% $355,796
Nan Fung Group Holdings Ltd 3.1% 58,347 0% 0.52% $310,406
SAMSARA BIOCAPITAL, LLC 2.6% 48,830 -6.9% 0.03% $259,776
Board of Trustees of The Leland Stanford Junior University 1.9% 35,978 0% 0.02% $191,400
VANGUARD GROUP INC 1.8% 34,231 -41% 0% $182,109
Pfizer Inc 1.6% 31,305 0% 0.04% $166,543
RENAISSANCE TECHNOLOGIES LLC 1.5% 28,625 +56% 0% $152,285
GEODE CAPITAL MANAGEMENT, LLC 0.97% 18,533 0% 0% $98,614
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.87% 16,642 0% $88,535
Shay Capital LLC 0.84% 15,958 0.02% $84,897
Squarepoint Ops LLC 0.78% 14,836 +20% 0% $78,928
DRW Securities, LLC 0.64% 12,322 0% $65,553
BlackRock, Inc. 0.51% 9,711 -8% 0% $51,662
MORGAN STANLEY 0.16% 3,128 -13% 0% $16,641
Tower Research Capital LLC (TRC) 0.01% 259 -34% 0% $1,378
JPMORGAN CHASE & CO 0% 42 -2.3% 0% $223
BANK OF AMERICA CORP /DE/ 0% 31 -89% 0% $165
SBI Securities Co., Ltd. 0% 10 0% 0% $53
BARCLAYS PLC 0% 6 0% $32
UBS Group AG 0% 3 -98% 0% $16
SALEM INVESTMENT COUNSELORS INC 0% 2 0% 0% $11
ADAR1 Capital Management, LLC 0% 0 -100% $0

Institutional Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 0 $0 -$11 $5.93 0
2025 Q3 804,036 $4,277,487 -$449,315 $5.32 24
2025 Q2 887,525 $5,096,477 +$5,096,477 $5.77 24